1-6 of 6
Andrew M Evens, DO, MSc, FACP
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Gray Zone Lymphoma (GZL) with Features Intermediate Between Diffuse Large B-Cell Lymphoma (DLBCL) and Classical Hodgkin Lymphoma (cHL): Pathologic Classification and Clinical Outcomes from a Multicenter Consensus Study

Andrew M Evens, DO, MSc, FACP, Monika Pilichowska, MD, Stefania Pittaluga, MD PhD, Judith Ferry, MD, Jessica Hemminger, MD, Jennifer A. Kanakry, Laurie H. Sehn, Tatyana Feldman, MD, Jeremy S. Abramson, MD, Francisco J. Hernandez-Ilizaliturri, MD, Izidore S Lossos, MD, Oliver W Press, MD PhD, Timothy S. Fenske, MD, Jonathan Friedberg, MD, Julie M Vose, MD, Kristie A. Blum, MD, Deepa Jagadeesh, Gaurav Gupta, MD PhD, Randy D Gascoyne, MD, Elaine Jaffe, MD
Journal: Blood
Blood (2016) 128 (22): 4145.
https://doi.org/10.1182/blood.V128.22.4145.4145
Published: 2016
Journal Articles

Proteasome and HDAC Inhibitor Therapy in T-Cell Lymphoma (TCL) and Hodgkin Lymphoma (HL): Nuclear Factor Erythroid 2 like 2 (NRF2)-Dependent Cell Death and Function

Frank C. Passero, Jr., MD, Ravi Dashnamoorthy, PhD, Afshin Beheshti, PhD, J. Tyson McDonald, PhD, Andrew M Evens, DO, MSc, FACP
Journal: Blood
Blood (2016) 128 (22): 3020.
https://doi.org/10.1182/blood.V128.22.3020.3020
Published: 2016
Journal Articles

Integrative Genetic and Clinical Analysis through Whole Exome Sequencing in 1001 Diffuse Large B Cell Lymphoma (DLBCL) Patients Reveals Novel Disease Drivers and Risk Groups

Jenny Zhang, Anupama Reddy, Cassandra Love, Andrea B. Moffitt, Deepthi Rajagopalan, Sirpa Leppä, Annika Pasanen, MD PhD, Leo Meriranta, MS, Marja-Liisa Karjalainen-Lindsberg, Peter H Norgaard, MD PhD, Mette Pederson, Anne Ortved Gang, Estrid Hogdall, Kristy L. Richards, PhD MD, Yuri D. Fedoriw, MD, Leon Bernal-Mizrachi, MD, Jean L. Koff, MD, Ashley D. Staton, MD, Christopher Flowers, MDMS, Ora Paltiel-Clarfield, Neta Goldschmidt, MD, Maria Calaminici, Andrew James Clear, John Gribben, Evelyn Nguyen, Magdalena Czader, MD PhD, Sarah Lynn Ondrejka, DO, Angela Collie, MD PhD, Eric D Hsi, MD, Rex au-Yeung, Kwong Yok-Lam, Wai Lap Choi, MD, Gopesh Srivastava, Andrew M Evens, DO, MSc, FACP, Monika Pilichowska, MD PhD, Manju Sengar, Nishitha Reddy, MD MSCI, MBBS, Shaoying Li, MD, Elaine S. Jaffe, MD, Tiffany Tzeng, Jyotishka Datta, David Dunson, Sandeep Dave, MD
Journal: Blood
Blood (2016) 128 (22): 1087.
https://doi.org/10.1182/blood.V128.22.1087.1087
Published: 2016
Journal Articles

Assessing the Risk of Cardiac Toxicity after Contemporary Treatment for Hodgkin Lymphoma (HL): A Multidisciplinary Systematic Review

Julie Fu, MD MA, Jenica Upshaw, MDMS, Michael J. Kelly, MD MPH, MS, Joshua T Cohen, PhD, Tully Saunders, MBA, Andrew M Evens, DO, MSc, FACP, Susan K Parsons, MDMRP
Journal: Blood
Blood (2016) 128 (22): 3564.
https://doi.org/10.1182/blood.V128.22.3564.3564
Published: 2016
Journal Articles

Buparlisib/BKM120 PI3 Kinase Therapy in B Cell and T Cell Non-Hodgkin Lymphoma (NHL) and Hodgkin Lymphoma (HL): Identification of Resistance Pathways and Biomarker Discovery

Afshin Beheshti, PhD, Michael E Coyle, MD, Ravi Dashnamoorthy, PhD, Andrew M Evens, DO, MSc, FACP
Journal: Blood
Blood (2016) 128 (22): 2920.
https://doi.org/10.1182/blood.V128.22.2920.2920
Published: 2016
Journal Articles

CD19 Target Activated Natural Killer (CD19.TaNK) Cellular Therapy: A Novel immunotherapeutic Approach to the Treatment of Non-Hodgkin Lymphoma (NHL)

Ravi Dashnamoorthy, PhD, Afshin Beheshti, PhD, Saheli Sarkar, PhD, Pooja Sabhachandani, Frank C. Passero, Jr., MD, Sneha Purvey, MD, Laurent Boissel, PhD, Tania Konry, Andrew M Evens, DO, MSc, FACP
Journal: Blood
Blood (2016) 128 (22): 4174.
https://doi.org/10.1182/blood.V128.22.4174.4174
Published: 2016